March 23, 2026

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 30.7% Upside Potential Amidst Strong Revenue Growth

Elevance Health, Inc. (NYSE: ELV), a key player in the healthcare plans industry, presents a compelling opportunity for investors seeking exposure in the healthcare sector. With a market capitalization of..

Medtronic plc (MDT) Stock Analysis: Unpacking a 29% Potential Upside in the Medical Device Giant

Medtronic plc (MDT), a leading player in the healthcare sector, has garnered significant attention from investors, particularly given its impressive market cap of $110.62 billion. Based in Ireland, Medtronic operates..

Regeneron Pharmaceuticals, Inc. (REGN) Investor Outlook: A Biotechnology Powerhouse with 19% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a dominant force in the biotechnology sector, offers a compelling opportunity for individual investors seeking exposure to healthcare innovation. With a robust market cap of..

Labcorp Holdings Inc. (LH) Stock Analysis: A 17% Potential Upside and Strong Buy Ratings Stand Out

Labcorp Holdings Inc. (NYSE: LH) is a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $21.8 billion, Labcorp provides essential..

Becton, Dickinson and Company (BDX) Stock Analysis: Unpacking a 27.91% Potential Upside for Investors

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, is capturing investor attention with a compelling potential upside of 27.91% according to recent analyst ratings. With a..

Sanofi (SNY) Stock Analysis: Exploring a 29% Potential Upside Amid Strategic Collaborations

Sanofi (NASDAQ: SNY), a titan in the healthcare sector and a leading figure in the Drug Manufacturers – General industry, is making waves with a substantial market capitalization of $108.62..

GSK plc (GSK) Stock Analysis: Evaluating a Solid 10.87% Potential Upside with a Strong Dividend Yield

GSK plc (GSK), a prominent name in the healthcare sector, has long been a stalwart in the drug manufacturing industry. With a robust market capitalization of $104.12 billion, GSK stands..

Boston Scientific Corporation (BSX) Stock Analysis: Unveiling a 47.5% Upside Potential in the Medical Device Industry

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence in the medical devices industry. Based in the..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 43.93% Potential Upside in Biotech

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its innovative approach and robust pipeline of therapeutics based on..

The Cigna Group (CI) Stock Analysis: Exploring a 28.90% Upside Potential in Healthcare Plans

The Cigna Group (NYSE: CI) stands as a formidable player in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $70.21 billion, The Cigna Group..

Thermo Fisher Scientific Inc (TMO): Investor Outlook on a Potential 39.96% Upside

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a titan in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $176.23 billion, this Waltham,..

AbbVie Inc. (ABBV) Stock Analysis: Unpacking a 21.49% Potential Upside Amid Healthcare Innovations

AbbVie Inc. (ABBV) stands as a formidable player in the healthcare sector, leveraging a robust portfolio of biopharmaceutical products and therapies. Incorporated in 2012 and headquartered in North Chicago, Illinois,..

Cencora, Inc. (COR) Stock Analysis: Exploring a 25% Potential Upside and Robust Revenue Growth in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a formidable player in the medical distribution industry, has been attracting attention from investors due to its promising financial metrics and growth potential. With a market..

CVS Health Corporation (CVS) Stock Analysis: Navigating a 35% Potential Upside Amidst Healthcare Expansion

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, continues to carve out a formidable presence in the healthcare plans industry. Headquartered in Woonsocket, Rhode Island, CVS operates..

McKesson Corporation (MCK) Stock Analysis: Exploring the Potential 12.62% Upside for Investors

McKesson Corporation (NYSE: MCK) stands as a formidable player in the healthcare sector, operating primarily within the medical distribution industry. With a robust market capitalization of $109.34 billion, McKesson is..

Eli Lilly and Company (LLY) Stock Analysis: Healthcare Giant Offers 33% Upside Potential

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, is catching the eye of investors with its impressive growth metrics and promising future potential. With a market..

Danaher Corporation (DHR) Stock Analysis: Navigating a 39.90% Potential Upside

Danaher Corporation (NYSE: DHR) stands as a stalwart in the healthcare sector, specifically within the Diagnostics & Research industry. With a robust market capitalization of $133.9 billion, this U.S.-based company..

Johnson & Johnson (JNJ) Stock Analysis: Revenue Growth Surges Amidst Healthcare Innovation

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to command investor attention with its formidable market capitalization of $567.22 billion. As a key player in the..

Novo Nordisk A/S (NVO) Investor Outlook: Exploring a 27.85% Upside Potential in the Healthcare Sector

Novo Nordisk A/S (NVO), a global leader in the healthcare sector, presents a compelling case for investors seeking exposure to the pharmaceutical industry. Headquartered in Bagsvaerd, Denmark, the company is..

Multi-product lending strategy targets stronger client retention and growth

A broader product offering is being used to grow client value and support more consistent lending income...
Search

Funds

March 23, 2026

Multi-product lending strategy targets stronger client retention and growth

A broader product offering is being used to grow client value and support more consistent lending income...
Search

Funds

March 23, 2026

FTSE 100

Funds